Anthony Labarca
Territory Business Manager at FeNO by NIOX® USA - Morrisville, North Carolina, United States
Anthony Labarca's Colleagues at FeNO by NIOX® USA
Anthony Labarca's Contact Details
New York,United States
FeNO by NIOX® USA
Anthony Labarca's Company Details
ASTHMA IS COMPLICATED. WE BELIEVE WE CAN MAKE IT SIMPLER.Airway inflammation is the major underlying cause of asthma. FeNO is a biomarker of Type 2 inflammation and FeNO testing can help achieve better management and outcomes in asthma patients.Circassia is the world leader in FeNO testing. Our NIOX® products are used by specialists throughout the US and around the world.NIOX®, THE GOLD STANDARD IN FENO TESTINGWith over 36 million FeNO tests performed worldwide, NIOX VERO® helps healthcare professionals to accurately measure Type 2 airway inflammation. NIOX® technology eliminates the impact of environmental nitric oxide and ensures you get an accurate FeNO result each time, every time. NIOX VERO® can help with:- Diagnosis: Identifying Type 2 inflammation and assisting in asthma diagnosis- Treatment: Identifying patients likely to respond to ICS and optimising ICS dosage- Compliance: Uncovering non-adherence to ICS treatment - Quality of life: Predicting exacerbations and reducing exacerbation rate by up to 50% (add ‘in patients at risk' for the US only)- Severe asthma: Identifying appropriate patients for some biologics and monitoring response to biologicsFind out more about NIOX VERO® here: https://niox.com